# FDA 483 - Eli Lilly & Company - October 17, 2022

Source: https://www.globalkeysolutions.net/records/483/eli-lilly-company/2c661ca0-ab81-49b5-8684-3a570c1c4a8d

> FDA 483 for Eli Lilly & Company on October 17, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eli Lilly & Company
- Inspection Date: 2022-10-17
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/15ef318d-09d2-403d-a119-ae8f9a4a6fc9)
- [483 - 2023-06-16](https://www.globalkeysolutions.net/records/483/eli-lilly-company/a0b48bb1-5ab9-46d0-aa9d-29cc5079a354)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/eli-lilly-company/fb465d0f-eee0-4efe-b1ef-fd636964c59d)
- [EIR - 2020-01-17](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/00535940-b628-4bcd-aa01-17eb95be770e)
- [483 - 2021-03-16](https://www.globalkeysolutions.net/records/483/eli-lilly-company/9fdf10fc-bc85-478c-affd-9279176c5cb7)

## Related Officers

- [Joseph A. Piechocki](https://www.globalkeysolutions.net/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)
- [Mercy Oyugi](https://www.globalkeysolutions.net/people/mercy-oyugi/9da8ebdc-a4c6-4666-9096-9a17f4edcf6c)
- [Nailing Zhang](https://www.globalkeysolutions.net/people/nailing-zhang/d3814d08-b799-4de1-b901-1b90da0e0178)
- [Investigator](https://www.globalkeysolutions.net/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)

Company: https://www.globalkeysolutions.net/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd